Press releases
- Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
- Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
- Ironwood Pharmaceuticals Reports First Quarter 2024 Results
- Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
- Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
- Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
More ▼
Key statistics
As of last trade, Ironwood Pharmaceuticals Inc (I76:DUS) traded at 5.85, 14.71% above the 52 week low of 5.10 set on Jun 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.85 |
---|---|
High | 5.85 |
Low | 5.85 |
Bid | 5.90 |
Offer | 6.05 |
Previous close | 5.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 158.96m |
Free float | 156.25m |
P/E (TTM) | -- |
Market cap | 1.03bn USD |
EPS (TTM) | -6.79 USD |
Data delayed at least 15 minutes, as of Jul 08 2024 11:30 BST.
More ▼